Clinical trial
A Prospective Observational Descriptive Study and Retrospective Chart Review of Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Descriptive Study and Retrospective Chart Review of Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
- Lead sponsor
- Amgen
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- August 31, 2008
- Enrollment
- 326 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic thrombocytopenic purpura, thrombocytopenia, thrombocytopenia in subjects with immune (idiopathic) thrombocytopenic purpura (itp), thrombocytopenic purpura